Pharmacodynamics of NOVOLOG After Intravenous Administration A double-blind, randomized, two-way crossover study in 16 patients with type 1 diabetes demonstrated that intravenous infusion of NOVOLOG resulted in a blood glucose profile that was similar to that after intravenous infusion with regular human insulin
Antioxidant Defense Elevated glutathione levels can help neutralize harmful free radicals, reducing cell damage and signs of aging
Plaintiffs will want more information while defendants will want to produce less
1 Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Denmark, 2 Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, 3 Zealand Pharma A/S, Sborg, Denmark, 4 Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, 5 Gentofte Hospital, Hellerup, Denmark, 6 Steno Diabetes Center Copenhagen, Herlev, Denmark, 7 Novo Nordisk, Sborg, Denmark
Our technical background allows us to handle sensitive patient data with the precision required for high-stakes clinical outcomes
10.1038/s41419-023-05716-0 10 ChengZ.YangL.LiM.ZhangQ.LiJ.ZhangN.et al (2025)
:format(webp))
